Skip to main content
. Author manuscript; available in PMC: 2015 Apr 16.
Published in final edited form as: J Carcinog Mutagen. 2013;(Spec Iss Apoptosis):S6-009. doi: 10.4172/2157-2518.S6-009

Figure 1.

Figure 1

ChIP-sequencing identifies IRF1 binding sites in H3396 breast cancer cells A. Shown are the number of peak regions identified in control (unstimulated) and IFN-gamma stimulated cells B. Positional chromosomal annotation (CEAS) of IRF1 bound peak regions represented as percent coverage. Shown is the set coverage for control, IFN-gamma unique (only found in IFN stimulated cells) and IFN-gamma total binding sites relative to the genome.